Lv2
146 积分 2024-01-15 加入
Neoadjuvant immunotherapy in mismatch-repair-proficient colon cancers
7天前
已完结
Ubiquinol-mediated suppression of mitochondria-associated ferroptosis is a targetable function of lactate dehydrogenase B in cancer
19天前
已完结
Long-acting IL-2 release from pressure-fused biomineral tablets promotes antitumor immune response
2个月前
已完结
Challenges of small cell lung cancer heterogeneity and phenotypic plasticity
3个月前
已完结
Long-acting IL-2 release from pressure-fused biomineral tablets promotes antitumor immune response
4个月前
已完结
Vein bypass first vs. best endovascular treatment first revascularisation strategy for chronic limb-threatening ischaemia due to infra-popliteal disease: the BASIL-2 RCT
6个月前
已完结
Outcomes of Endovascular-First Versus Bypass-First Approach for Patients With Chronic Limb-Threatening Ischemia Using a Medicare-Linked Database
6个月前
已完结
Bypass surgery versus endovascular intervention for lower extremity revascularization in patients with chronic renal disease or end-stage renal disease: a systematic review and meta-analysis
6个月前
已完结
Surgery or endovascular therapy for patients with chronic limb-threatening ischemia requiring infrapopliteal interventions
6个月前
已完结
Secondary interventions following open vs endovascular revascularization for chronic limb threatening ischemia in the BEST-CLI trial
6个月前
已完结
皖公网安备34019202002308
